Celanese stock hits 52-week low of $66.71 amid market woes By Investing.com

Celanese Corporation (NYSE: ), a global chemicals and specialty materials company, saw its stock price hit a 52-week low, reaching $66.71. Trading at a P/E ratio of 6.74x and offering a 4.09% dividend yield, which has been maintained for 20 consecutive years, the stock appears to be worth following InvestingPro the exam. This price level reflects a significant decline in the company’s performance over the past year, while Celanese’s stock has experienced a significant one-year change, falling by -55.37%. Investors are watching the stock closely as it navigates a difficult market environment, which has led to this notable drop from its valuation last year. With reviewer pricing ranging from $73 to $150, and 8 other key features available at InvestingProThe company’s strategic plans and market conditions in the coming months will be important for recovery and investor confidence.

In other recent news, Celanese Corporation has experienced major changes and challenges. The company recently announced the appointment of Christopher Kuehn, Executive Vice President and Chief Financial Officer at Trane Technologies (NYSE:), to its Board of Directors. Celanese also made significant leadership changes, appointing Scott Richardson as its new CEO and Edward Galante as its new Chairman of the Board.

However, the company’s financial performance has been troubling. Earnings expectations for the future were revised downward by 18 analysts, and the company’s third quarter earnings in 2024 were affected by the market. Fourth-quarter earnings are expected to decline significantly, leading to the company’s planned quarterly dividend reduction in the first quarter of 2025 to lower its net debt-to-EBITDA ratio.

Several analyst firms, including UBS, BMO Capital Markets, and Piper Sandler, lowered their ratings for Celanese due to concerns about the company’s ability to manage its debt and the impact of a weaker environment. more than expected macroeconomics. Despite these challenges, Celanese is focused on reducing costs, delivering synergies, improving the Engineered Materials pipeline, and leveraging the Acetyl Chain. However, a potential merger with Blackstone (NYSE: ) for Acetow has been ruled out due to regulatory concerns. These are the latest updates from Celanese Corporation.

This article was created with the support of AI and reviewed by the editor. For more details, see our T&C.